Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ludwig

Showing results (61-70 of 231) with videos related to

Pageof 24
Sort By:
Viruses|October 26, 2021
Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral TargetsJens Kleinehr, Janine J Wilden, Yvonne Boergeling, et al.
Plos One|February 14, 2014
The Rac1 inhibitor NSC23766 exerts anti-influenza virus properties by affecting the viral polymerase complex activityRüdiger Dierkes, Kathrin Warnking, Swantje Liedmann, et al.
The Journal of Biological Chemistry|November 6, 2013
Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infectionYvonne Börgeling, Mirco Schmolke, Dorothee Viemann, et al.
Dalton Transactions (Cambridge, England : 2003)|December 12, 2022
Tuning the potential of redox-active diphosphine ligands based on the alkyne complexes [Tp*W(CO)L{η<sup>2</sup>-C<sub>2</sub>(PPh<sub>2</sub>)<sub>2</sub>}]Stephan Ludwig, Friederike M Hamann, Kai Helmdach, et al.
Journal of Leukocyte Biology|March 24, 2012
Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophagesJudith Friesenhagen, Yvonne Boergeling, Eike Hrincius, et al.
Journal of Virology|July 2, 2010
The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral stateSabine Eva Dudek, Christina Luig, Eva-Katharina Pauli, et al.
Emerging Microbes & Infections|March 15, 2019
The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivoSebastian Schloer, Jonas Goretzko, Alexander Kühnl, et al.
Journal of Virology|July 13, 2012
The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cellsAndrea Rückle, Emanuel Haasbach, Ilkka Julkunen, et al.
The Journal of Biological Chemistry|September 13, 2008
Interaction between S100A8/A9 and annexin A6 is involved in the calcium-induced cell surface exposition of S100A8/A9Günther Bode, Aloys Lüken, Claus Kerkhoff, et al.
Microbes and Infection|September 29, 2009
Interplay between influenza A virus and the innate immune signalingChristina Ehrhardt, Roman Seyer, Eike R Hrincius, et al.
Pageof 24

Showing results (61-70 of 231) with videos related to

Sort By:
Pageof 24
Viruses|October 26, 2021
Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral TargetsJens Kleinehr, Janine J Wilden, Yvonne Boergeling, et al.
Plos One|February 14, 2014
The Rac1 inhibitor NSC23766 exerts anti-influenza virus properties by affecting the viral polymerase complex activityRüdiger Dierkes, Kathrin Warnking, Swantje Liedmann, et al.
The Journal of Biological Chemistry|November 6, 2013
Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infectionYvonne Börgeling, Mirco Schmolke, Dorothee Viemann, et al.
Dalton Transactions (Cambridge, England : 2003)|December 12, 2022
Tuning the potential of redox-active diphosphine ligands based on the alkyne complexes [Tp*W(CO)L{η<sup>2</sup>-C<sub>2</sub>(PPh<sub>2</sub>)<sub>2</sub>}]Stephan Ludwig, Friederike M Hamann, Kai Helmdach, et al.
Journal of Leukocyte Biology|March 24, 2012
Highly pathogenic avian influenza viruses inhibit effective immune responses of human blood-derived macrophagesJudith Friesenhagen, Yvonne Boergeling, Eike Hrincius, et al.
Journal of Virology|July 2, 2010
The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral stateSabine Eva Dudek, Christina Luig, Eva-Katharina Pauli, et al.
Emerging Microbes & Infections|March 15, 2019
The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivoSebastian Schloer, Jonas Goretzko, Alexander Kühnl, et al.
Journal of Virology|July 13, 2012
The NS1 protein of influenza A virus blocks RIG-I-mediated activation of the noncanonical NF-κB pathway and p52/RelB-dependent gene expression in lung epithelial cellsAndrea Rückle, Emanuel Haasbach, Ilkka Julkunen, et al.
The Journal of Biological Chemistry|September 13, 2008
Interaction between S100A8/A9 and annexin A6 is involved in the calcium-induced cell surface exposition of S100A8/A9Günther Bode, Aloys Lüken, Claus Kerkhoff, et al.
Microbes and Infection|September 29, 2009
Interplay between influenza A virus and the innate immune signalingChristina Ehrhardt, Roman Seyer, Eike R Hrincius, et al.
Pageof 24